Nomura Asset Management CO LTD Biomarin Pharmaceutical Inc Transaction History

Nomura Asset Management CO LTD

  • $31.8 Billion
  • Q3 2024

A detailed history of Nomura Asset Management CO LTD transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Nomura Asset Management CO LTD holds 485,609 shares of BMRN stock, worth $32.6 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
485,609
Previous 374,926 29.52%
Holding current value
$32.6 Million
Previous $30.9 Million 10.58%
% of portfolio
0.11%
Previous 0.11%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024
BUY
$69.02 - $93.84 $7.64 Million - $10.4 Million
110,683 Added 29.52%
485,609 $34.1 Million
Q2 2024

Aug 14, 2024
SELL
$74.43 - $92.22 $4.6 Million - $5.7 Million
-61,829 Reduced 14.16%
374,926 $30.9 Million
Q1 2024

May 13, 2024
BUY
$83.81 - $99.0 $4.94 Million - $5.84 Million
58,984 Added 15.61%
436,755 $38.1 Million
Q4 2023

Feb 09, 2024
SELL
$76.22 - $98.51 $329,499 - $425,858
-4,323 Reduced 1.13%
377,771 $36.4 Million
Q3 2023

Nov 03, 2023
BUY
$85.07 - $94.48 $7.83 Million - $8.7 Million
92,045 Added 31.73%
382,094 $33.8 Million
Q2 2023

Aug 14, 2023
BUY
$86.68 - $100.3 $6.01 Million - $6.95 Million
69,328 Added 31.41%
290,049 $25.1 Million
Q1 2023

May 11, 2023
BUY
$87.74 - $117.27 $10.9 Million - $14.6 Million
124,701 Added 129.87%
220,721 $21.5 Million
Q4 2022

Feb 14, 2023
SELL
$80.93 - $108.63 $632,467 - $848,943
-7,815 Reduced 7.53%
96,020 $9.94 Million
Q3 2022

Nov 10, 2022
BUY
$82.16 - $96.94 $466,258 - $550,134
5,675 Added 5.78%
103,835 $8.8 Million
Q2 2022

Aug 12, 2022
BUY
$71.48 - $86.85 $499,645 - $607,081
6,990 Added 7.67%
98,160 $8.13 Million
Q1 2022

May 13, 2022
BUY
$74.28 - $92.69 $136,080 - $169,808
1,832 Added 2.05%
91,170 $7.03 Million
Q4 2021

Feb 01, 2022
BUY
$71.72 - $91.47 $831,952 - $1.06 Million
11,600 Added 14.92%
89,338 $7.89 Million
Q3 2021

Nov 12, 2021
SELL
$74.77 - $85.47 $386,635 - $441,965
-5,171 Reduced 6.24%
77,738 $6.01 Million
Q2 2021

Aug 06, 2021
SELL
$75.51 - $84.79 $7.28 Million - $8.17 Million
-96,361 Reduced 53.75%
82,909 $6.92 Million
Q1 2021

May 14, 2021
BUY
$74.73 - $90.69 $665,097 - $807,141
8,900 Added 5.22%
179,270 $13.5 Million
Q4 2020

Feb 12, 2021
SELL
$72.61 - $90.2 $15.1 Million - $18.8 Million
-208,110 Reduced 54.99%
170,370 $14.9 Million
Q3 2020

Nov 12, 2020
BUY
$71.87 - $131.03 $8.18 Million - $14.9 Million
113,808 Added 43.0%
378,480 $28.8 Million
Q2 2020

Aug 13, 2020
BUY
$79.55 - $124.22 $14.7 Million - $22.9 Million
184,647 Added 230.74%
264,672 $32.6 Million
Q1 2020

May 14, 2020
BUY
$71.37 - $96.85 $142,954 - $193,990
2,003 Added 2.57%
80,025 $6.76 Million
Q4 2019

Feb 13, 2020
BUY
$64.27 - $86.37 $449 - $604
7 Added 0.01%
78,022 $6.6 Million
Q3 2019

Nov 13, 2019
BUY
$67.4 - $85.11 $169,645 - $214,221
2,517 Added 3.33%
78,015 $5.26 Million
Q2 2019

Aug 13, 2019
SELL
$80.35 - $93.9 $16,069 - $18,780
-200 Reduced 0.26%
75,498 $6.47 Million
Q1 2019

May 10, 2019
SELL
$84.2 - $98.62 $601,272 - $704,245
-7,141 Reduced 8.62%
75,698 $6.72 Million
Q4 2018

Feb 12, 2019
SELL
$80.14 - $106.07 $63,711 - $84,325
-795 Reduced 0.95%
82,839 $7.05 Million
Q3 2018

Nov 07, 2018
SELL
$93.92 - $105.72 $3.23 Million - $3.64 Million
-34,384 Reduced 29.13%
83,634 $8.11 Million
Q2 2018

Aug 03, 2018
BUY
$76.01 - $99.03 $340,372 - $443,456
4,478 Added 3.94%
118,018 $11.1 Million
Q1 2018

May 14, 2018
BUY
$77.67 - $92.63 $445,282 - $531,047
5,733 Added 5.32%
113,540 $9.21 Million
Q4 2017

Feb 14, 2018
BUY
$80.76 - $95.13 $397,904 - $468,705
4,927 Added 4.79%
107,807 $9.61 Million
Q3 2017

Nov 13, 2017
BUY
$80.6 - $94.95 $591,362 - $696,648
7,337 Added 7.68%
102,880 $9.57 Million
Q2 2017

Aug 14, 2017
BUY
N/A
95,543
95,543 $8.68 Million

Others Institutions Holding BMRN

# of Institutions
638
Shares Held
178M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.5B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email